L. Lanfumey et al., EFFECTS OF CHRONIC DIAZEPAM TREATMENT ON PRESYNAPTIC AND POSTSYNAPTIC5-HT1A RECEPTORS IN THE RAT-BRAIN, European journal of pharmacology, 323(2-3), 1997, pp. 137-148
Biochemical and electrophysiological approaches were used to assess po
ssible changes in 5-HT1A receptors in the rat brain after long-term tr
eatment with an anxiolytic benzodiazepine. Rats were treated with diaz
epam (2 mg/kg i.p. daily) during 14 days and then untreated for 1 day
(protocol A) or 5 days (protocol C) until they were killed for in vitr
o investigations on 5-HT1A receptors. In addition, other rats (protoco
l B) received the same 14-day treatment with diazepam, followed by 1 m
g/kg of the drug on days 15 and 16, and 0.5 mg/kg on days 17 and 18, a
nd were killed 24 h after the last injection. In vitro binding and qua
ntitative autoradiographic experiments with [H-3]8-hydroxy-2-(di-n-pro
pylamino)tetralin ([H-3]8-OH-DPAT) showed that the characteristics of
5-HT1A receptor binding sites in the hippocampus and the dorsal raphe
nucleus were not significantly altered by the administration of diazep
am under the treatment protocols A, B and C. Furthermore, in vitro ele
ctrophysiological recordings of serotoninergic neurons in the dorsal r
aphe nucleus of brain stem slices revealed no modification in the sens
itivity of somatodendritic 5-HT1A autoreceptors in rats treated with d
iazepam according to the protocols A and B. However, under the conditi
ons of protocol C, the potency of 8-OH-DPAT to depress the firing rate
of serotoninergic neurons was significantly enhanced, as expected of
a hypersensitivity of somatodendritic 5-HT1A autoreceptors. These data
support the hypothesis that some functional changes in these receptor
s could occur during benzodiazepine withdrawal. However, they do not s
upport the idea of a reduced anxiolytic efficacy of 5-HT1A receptor ag
onists as a result of prior treatment with a benzodiazepine. (C) 1997
Elsevier Science B.V.